Kraj: Malta
Język: angielski
Źródło: Malta Medicines Authority
DOMPERIDONE
Janssen-Cilag International NV Turnhoutseweg 30, B-2340 Beerse, Belgium
A03FA03
DOMPERIDONE 30 mg
SUPPOSITORY
DOMPERIDONE 30 mg
POM
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
Withdrawn
2007-01-30
1 PACKAGE LEAFLET: INFORMATION FOR THE USER MOTILIUM ® 30 MG SUPPOSITORIES (30 mg domperidone per suppository) This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. _ _ WHAT IS IN THIS LEAFLET 1. What MOTILIUM is and what it is used for 2. What you need to know before you take MOTILIUM 3. How to take MOTILIUM 4. Possible side effects 5. How to store MOTILIUM 6. Contents of the pack and other information. 1. WHAT MOTILIUM IS AND WHAT IT IS USED FOR MOTILIUM suppositories are used in adults to treat nausea (feeling sick) and vomiting (being sick). 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE MOTILIUM DO NOT TAKE MOTILIUM IF YOU: are allergic (hypersensitive) to domperidone or any of the other ingredients of MOTILIUM have stomach bleeding or if you regularly have severe abdominal pain or persistent black stools (poo) have a blocked or perforated gut have a tumour of the pituitary gland (prolactinoma) have a moderate or severe liver disease have an ECG (electrocardiogram) that shows a heart problem called “prolonged QT interval” have Przeczytaj cały dokument
1 This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions. See section 4.8 for how to report adverse reactions. 1. NAME OF THE MEDICINAL PRODUCT Motilium ® 30mg suppositories 2. QUALITATIVE AND QUANTITATIVE COMPOSITION One suppository contains domperidone 30 mg. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM _Suppositories _ White to slightly yellow suppositories. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Motilium is indicated for the relief of the symptoms of nausea and vomiting. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Motilium should be used at the lowest effective dose for the shortest duration necessary to control nausea and vomiting. Patients should try to take each dose at the scheduled time. If a scheduled dose is missed, the missed dose should be omitted and the usual dosing schedule resumed. The dose should not be doubled to make up for a missed dose. Usually, the maximum treatment duration should not exceed one week. Adults, and adolescents (12 years of age and older and weighing 35 kg or more) _Suppositories _ One 30 mg suppository inserted into the rectum two times per day. Neonates, infants, children (less than 12 years of age) and adolescents weighing less than 35 kg _Suppositories _ Due to the need for accurate dosing, suppositories are unsuitable for use in children and adolescents weighing less than 35 kg. Use of the oral suspension is recommended in these patients. Hepatic impairment Motilium is contraindicated in moderate or severe hepatic impairment (see section 4.3). Dose modification in mild hepatic impairment is however not needed (see sectio Przeczytaj cały dokument